Idiopathic thromboembolism has been associated with occult neoplasia ; however, very limited information exists regarding a man's risk of occult prostate cancer after an idiopathic thromboembolic event.
We performed a case-control study of 209 consecutive men diagnosed with prostate cancer over a 3-year period, with 350 men diagnosed with benign prostatic hyperplasia (BPH) serving as control subjects.
Men with idiopathic thromboembolism had a fivefold increased risk of prostate cancer compared with the BPH control group (risk ratio=5.0, P=0.002).
The prostate-specific antigen (PSA) progression-free survival was not adversely affected after an idiopathic thromboembolic event.
Our data suggest that men with idiopathic thromboembolism are at an increased risk for being diagnosed with prostate cancer.
In men with idiopathic thromboembolism, attempts to diagnose prostate cancer, including digital rectal examination and serum PSA, warrant consideration.
Mots-clés Pascal : Thrombose, Veine profonde, Risque, Adénocarcinome, Prostate, Association morbide, Dépistage, Etude statistique, Homme, Appareil circulatoire pathologie, Vaisseau sanguin pathologie, Veine pathologie, Tumeur maligne, Appareil urinaire pathologie, Appareil génital mâle pathologie, Prostate pathologie
Mots-clés Pascal anglais : Thrombosis, Deep vein, Risk, Adenocarcinoma, Prostate, Concomitant disease, Medical screening, Statistical study, Human, Cardiovascular disease, Vascular disease, Venous disease, Malignant tumor, Urinary system disease, Male genital diseases, Prostate disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0276442
Code Inist : 002B14D02. Création : 27/11/1998.